ClinicalTrials.Veeva

Menu
D

DelRicht Research | Gulfport Memorial

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Elismetrep
K-304

Parent organization

This site is a part of DelRicht Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 8 total trials
New

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

This is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.

Begins enrollment this month
Acute Migraine
Drug: Placebo
Drug: Elismetrep

This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with plac...

Begins enrollment this month
Migraine
Drug: Placebo
Drug: Elismetrep

The purpose of this study is to evaluate how well CD388 works in preventing symptomatic laboratory-confirmed influenza infections, as compared to pla...

Active, not recruiting
Influenza
Combination Product: CD388 Injection
Combination Product: Placebo

Trial sponsors

K
Moderna logo
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems